医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

AIRS Medical Receives FDA 510(k) Clearance for AI-Powered MRI Reconstruction Software SwiftMR™

2021年11月17日 AM12:00
このエントリーをはてなブックマークに追加


 

SEOUL, South Korea

AIRS Medical Inc., a healthcare startup based in South Korea, announced FDA 510(k) clearance of its first product SwiftMR™. SwiftMR™ is an AI-powered MRI reconstruction software that enhances MR images acquired under various conditions, contributing to higher throughput and better patient experience.

MRI scans are a safe and reliable source of imaging, but a single procedure takes 20-90 minutes, causing discomfort to patients and sometimes requiring sedation. Hence radiologists are forced to yield image quality to keep scan time at a patient-tolerant level. In addition, long scan times and hiking demand make MRI notorious for wait times that can build up to months.

AIRS Medical tackles this dilemma by utilizing deep learning engines trained with high-quality images to enhance low-quality images. Because the software communicates directly and automatically with the institution’s PACS (Picture Archiving and Communication System), it easily boosts performance and efficiency of the entire fleet of MRIs with a quick installation.

Since its launch in July, SwiftMR™ now serves numerous institutions across Korea, with over 4,000 patients scanned and zero downtime to date. The solution is gaining traction fast, as the output images are receiving positive feedback from radiologists in the country and abroad. “Refocusing our goal from increasing quantitative metrics of the deep learning engine to satisfying seasoned radiologists has been critical in advancing the technology to a clinically acceptable level,” said Jingu Lee, CEO of AIRS Medical. “We believe we can meaningfully reduce scan and wait times – and ultimately, enable medical imaging services to be more accessible to people around the world.”

AIRS Medical will showcase its market-ready product for the first time in the U.S. at RSNA 2021, where Dr. Jongho Lee, Professor of Seoul National University and scientific advisor of AIRS Medical, will give a presentation on the real-world application of SwiftMR™.

About AIRS Medical

AIRS Medical endeavors to transform the healthcare paradigm with cutting-edge technology. Founded in 2018 by a team of MR scientists and a doctor, AIRS has demonstrated unparalleled deep learning technology, most prominently through “assertively scoring the best in all evaluation phases” in the 2020 fastMRI Challenge hosted by Facebook AI Research and NYU Langone Health. For more information, visit www.airsmed.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211116005024/en/

CONTACT

Christina Kang

Head of Sales & Marketing

AIRS Medical

+82 7077773187

bd@airsmed.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Xlear Files Amended Answer to the Government’s Lawsuit on COVID-19 Statements; Provides Still More Data In Support of Xlear’s Use as Additional Layer of Protection
  • EpiAxis Therapeutics & Peptilogics Enter Strategic Drug Discovery Partnership
  • BeiGene Announces Strategic Alliance with Ontada to Improve U.S. Community Oncology Care
  • ENHERTU® Significantly Delayed Disease Progression in DESTINY-Breast02 Phase 3 Trial Versus Physician’s Choice of Treatment in Patients with HER2 Positive Metastatic Breast Cancer
  • Arbitrator Rules in Favor of Daiichi Sankyo in Dispute with Seagen